Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling
about
Effect of platelet-derived growth factor isoforms in rat metanephric mesenchymal cellsAn interstitial network of podoplanin-expressing cells in the human endolymphatic ductAdditive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell developmentOverview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidP-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironmentsIncreased serum and musculotendinous fibrogenic proteins following persistent low-grade inflammation in a rat model of long-term upper extremity overuseLRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activationBlood vessels as targets in tumor therapyRole of platelet-derived growth factors in physiology and medicineHigh interstitial fluid pressure - an obstacle in cancer therapyRole of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangementDeterministic model of dermal wound invasion incorporating receptor-mediated signal transduction and spatial gradient sensing.Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility.Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenationMulticentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastomaIncreased fibrosis and interstitial fluid pressure in two different types of syngeneic murine carcinoma grown in integrin β3-subunit deficient mice.Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.Functions and mechanisms of receptor tyrosine kinase Torso signaling: lessons from Drosophila embryonic terminal development.Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms.Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for managementCooperation between the PDGF receptors in cardiac neural crest cell migration.Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts.Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.Integrin alphavbeta3 acts downstream of insulin in normalization of interstitial fluid pressure in sepsis and in cell-mediated collagen gel contractionSafety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRαAdvances in treatment of chronic myelogenous leukemia--new treatment options with tyrosine kinase inhibitors.Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature.Vascular smooth muscle cell motility: From migration to invasion.Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib.Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience.PDGF, pericytes and the pathogenesis of idiopathic basal ganglia calcification (IBGC).Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.PDGF-BB enhances collagen gel contraction through a PI3K-PLCγ-PKC-cofilin pathwayA safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma.Double target for tumor mass destruction.Retention of PDGFR-beta function in mice in the absence of phosphatidylinositol 3'-kinase and phospholipase Cgamma signaling pathways.
P2860
Q24292157-390FD210-90EF-4071-9E2A-36F6383B8824Q24646973-EFB3DDC3-C0E5-44A3-A95F-56375F72B1BBQ24806905-ABE19745-D0E3-42FF-B8CA-FC5602785E4BQ26799981-3ED9086E-449B-439F-BE66-087E03CE8FAEQ27320507-97A3F87E-F666-4924-9052-0A209BF81E4AQ28387881-B4B38FA9-7DA9-4357-A623-BA46E9B7B285Q28508492-36366DE5-ECA2-4917-A52A-FEFFC6DE1DE5Q28590737-89C7548B-529B-4248-9686-0391B891CBE1Q29615222-CD44809E-E959-4827-828E-C501BDB17B71Q29619719-59DBF937-799D-40B0-99C1-0B5CDFE298E8Q30160287-FBE96E92-D7F5-4B4F-BF37-A89D16335486Q30476972-6A4CAD7A-835C-47F8-9A8C-42B65FAECC2BQ30835829-BF79699D-2657-49ED-B6AB-3594658F74F9Q33258552-60F53E40-D28C-4792-B9EC-236EBB2C71E3Q33387009-71366E35-2F05-463D-9DD0-FBF48214F1FDQ34222093-8F0D0A30-9A95-4985-8945-6BBE7DDCB774Q34343317-CCD2A0D4-88D1-40E5-AD56-470317B58DADQ34974027-F7EA81FE-6167-468D-9AA2-BB2E59E9F08FQ35002367-AF2D7906-07B1-48C1-B8FC-1D38D47A91D7Q35082777-7FDB8EB3-5DC3-4632-9575-750F491D1446Q35140171-C9D5D204-15D0-497E-9CA3-55321CD7636BQ36088538-E632B3CE-468A-4A67-97BC-03D2A479E255Q36611170-F85B3E01-A75F-4384-8204-C355604A679FQ36680668-CE386DC5-E1C2-4E65-A452-E8D11E0E10FFQ36844554-265246B6-85FB-4852-AB42-901961700934Q36926767-188BE810-3FE1-405F-B9DA-14931511B5F2Q37433981-BF864ADF-F186-4F78-AF93-CEFF44B60552Q37461467-12396A90-F732-4F2B-ABC4-8925FC9F23E0Q37657488-8B5EFFEB-1788-441B-A9A5-1428ABA97D4EQ37761374-B79E4BF5-E5EF-4CEA-9793-18E54ED6C5B6Q37832151-B5639828-555B-4622-A30F-705835A34F19Q37930709-FB3ABC0B-6277-4542-8799-DB741D064F4AQ38101103-4F078FB8-4C1B-4129-A9F9-6CFE10C3F7DEQ38221603-68CA4D19-21CD-44B0-9DC6-CAF2544069BAQ38246305-A6C0D233-5F61-4528-8173-C1C1C87C501AQ38615308-BA673FBD-3DA2-4C16-BD50-C2986374BA6CQ38729029-03F11D52-6E22-4DAD-8687-D90F8B88972CQ38848018-796FD8E0-75A0-47BC-B20C-F730AEF20C66Q39750399-868F4CBC-2D26-40CC-9536-026DD03C4168Q40445775-37F1A1FF-AD2A-49D0-A4DB-517E5D7AFB86
P2860
Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@ast
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@en
type
label
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@ast
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@en
prefLabel
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@ast
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@en
P2093
P2860
P50
P356
P1476
Platelet-derived growth factor ...... ylinositol-3' kinase signaling
@en
P2093
P2860
P304
11410-11415
P356
10.1073/PNAS.96.20.11410
P407
P577
1999-09-01T00:00:00Z